Therapeutics

Latest Innovations

A Novel Treatment for Fragile X Synaptic and Cognitive Deficits

Fragile X syndrome (FX) is the most common form of inherited intellectual disability and occurs in roughly 1:3,600 males and 1:8,000 females. Physical features associated...

Ionic Helical Polypeptides - Non-Viral Gene Delivery with Improved Transfection Efficiency

 

Tremendous potential exists for helical polypeptides that are water soluble (ionic) and remain stable at physiological conditions,...

Algorithm Modified Deoxynybomycin for the Treatment of Gram-Negative Bacteria

Dr. Hergenrother from the University of IL has developed a novel antibiotic that is effective against certain antibiotic-resistant gram-negative bacteria. His powerful...

A Pro-Apoptotic Microbial Community Network Enriched in the Tissue of IPF and Lung Cancer Patients

 

 

Dr. Isaac Cann from the University of Illinois has identified biomarkers and therapeutic strategy for treatment of...

pH Activated Antimicrobial Peptides for Treatment of H pylori Infection

Dr. JJ Cheng from the University of IL has developed a helix/random confirmation switchable antimicrobial polypeptides (HRS-AMPs) that are pH sensitive and can kill...

New Drug to Reverse Alzheimer’s Disease

 

Dr. Moore has developed a new drug that could reverse the progression of Alzheimer’s disease. The drug breaks up amyloid fibrils, which are believed to be the root cause...

Novel Class of Anti-Estrogens

Drs. John and Benita Katzenellenbogen have developed a novel class of anti-estrogen compounds with the potential to act as breast cancer therapeutics. These compounds show...

Dearomative Carboamination and its Application in Synthesis of Anticancer Agents 

Dr. Sarlah from the University of Illinois at Urbana-Champaign has developed a new synthesis method for the anticancer...

Pages